INTRODUCTION
Since the first reported clinical successes with intracytoplasmic sperm injection (ICSI) (1), a flurry of research and publication has ensued. Numerous aspects of this technique have been addressed, including indications for usage (2) (3) (4) ; various factors affecting outcome (female age) (5, 6) , sperm characteristics (7), sperm maturational stage (8) , sperm deposition site (9) , and mode of oolemma breakage (10) ; sperm preparation techniques (11) ; mechanism of oocyte activation (12) (13) (14) ; outcome of frozen-thawed ICSI embryos (15) ; and incidence of chromosomal (16) and structural abnormalities (17, 18) in resulting children. To date, ICSI performed on human gametes has been conducted primarily utilizing "viable" sperm; however, previous investigations have reported the birth of live offspring in animals and, most recently, in humans with injection of immobilized/"nonviable" sperm (19) (20) (21) . If normal embryos and normal resulting offspring are achievable from this technique with usage of nonviable sperm, then ICSI would provide a means for reproduction for men with necrospermia. The objective of our study was, therefore, to determine the ability of nonviable sperm to fertilize human oocytes and the early developmental normalcy of the resulting embryos.
MATERIALS AND METHODS

Patients
Prior to its initiation, this study protocol and consent form were approved by the Institutional Review Board of Eastern Virginia Medical School. Non-male-factor IVF couples and oocyte donors in Series 58 to 60 (January through September 1995) at The Jones Institute for Reproductive Medicine were asked to sign an informed consent donating their surplus immature oocytes to this study. Ovarian stimulation was accomplished using a combination of leuprolide acetate (Lupron; TAP Pharmaceuticals, Deerfield, IL), Metrodin, and Pergonal (Serono Laboratories Inc., Norwell, MA). Transvaginal oocyte retrieval was performed 34 to 36 hr after administration of hCG. Most of the retrieved oocytes were mature (metaphases I and II) and therefore used by the patient herself or by the oocyte recipient and not for this study. The remaining prophase I (PI) oocytes were used in the study. Following overnight incubation in Ham's F-10 medium (GIBCO Laboratories, Grand Island, NY) supplemented with 7.5% human fetal cord serum and extrusion of the first polar body, each patient's donated oocytes were randomized into two groups and injected with either a viable or a nonviable sperm.
Sperm Preparation
The sperm samples used were obtained either from the spouse in the case of the tVF patients or from consenting semen donors in the case of oocyte donors. When husband's sperm was used, the sample was collected and processed by swim-up for IVF the previous day and stored on the bench at room temperature. When donor sperm was used, the only variation in preparation was the initial thawing procedure, as all donor samples had previously been frozen. Following the standard swim-up, each sample was divided into two aliquots. One aliquot was frozen in'liquid nitrogen without a cryoprotectant, followed by rapid thawing in a 37°C water bath. A 15-1xl sample of this aliquot was then mixed with 5 Ixl of eosin stain and evaluated for the percentage of nonviable sperm (head absorbed red stain) in the sample. This freezing procedure was repeatedly performed on this aliquot until 100% of the sperm in the stained sample were "nonviable." Samples typically required two freezing procedures for the entire sample to have all sperm absorb the eosin stain. The second aliquot remained untreated and was designated the "viable" aliquot.
Injection Procedure
Micropipettes were produced using a Sutter pipette puller (P-87; Sutter Instruments Co., Navato, CA) and a Narishige microforge (MF-9; Narishige, Tokyo). The inner diameters of the holding and injection pipettes were 35 and 5 to 7 txm~ respectively. A sharp bevel was placed on the injection pipette by grinding the tip to a 45 ° angle with a Narishige grinder (EG-4; Narishige), followed by the production of a spike. Sperm delivery by the ICSI pipette was controlled by the use of a picoinjector (PLI-100; Medical Systems Corp., Greenvale, NY).
The injection procedure was conducted in a 50-to 100-txl droplet (one droplet per oocyte) of Earle's medium (GIBCO) supplemented with 15% human fetal cord serum over which was placed washed Squibb mineral oil (Roberts Pharmaceuticals, Eatontown, N J). A small volume of each sperm suspension (viable and nonviable) was then placed in droplets of 10% PVP (MW 360,000; ICN Pharmaceuticals, Costa Mesa, CA), which had been made up using Ham's F-10 medium (GIBCO) supplemented with 7.5% human fetal cord serum.
Both viable and nonviable sperm were struck in the midpiece region by the tip of the injection pipette. Each sperm was then aspirated tail first into the pipette and moved to the droplet of medium containing the oocyte. An oocyte was held securely in place by the holding pipette while the injection pipette pierced through the zona pellucida and into the cytoplasm. To assure oocyte activation, a small amount of cytoplasm was initially drawn up into the injection pipette and then expelled along with the sperm. Following completion of the microinjection procedure, the injection needle was withdrawn from the cytoplasm and the oocyte released from the holding pipette. Each oocyte was then washed in fresh culture medium and returned to the incubator. Fertilization of the surgically injected oocyte was assessed 18 hr later and cleavage was evaluated every 24 hr for 4 days.
RESULTS
A total of 27 patients consented to donate their immature (PI) oocytes for use in this study. Of the 124 oocytes obtained, 74 (59.7%) matured in vitro as documented by extrusion of the first polar body. Following randomization of each patient's oocytes into the two study groups, 37 oocytes were injected with viable sperm and 37 were injected with nonviable sperm.
The fertilization and cleavage results are presented in Table I . A significantly higher (P = 0.0001; chisquare analysis) normal two-pronuclei fertilization rate was obtained when oocytes were injected with viable sperm compared to when they were injected with nonviable sperm (62.2 vs 16.2%, respectively). O0cytes injected with viable sperm also demonstrated a higher cleavage rate, with many embryos cleaving beyond the two-cell stage. In contrast, only two of the six embryos resulting from injection of nonviable sperm cleaved, each only once and with both exhibiting >50% fragmentation.
DISCUSSION
The ability of the human oocyte to survive ICSI was first documented in 1988 by Lanzendorf and coworkers (19) . In that preclinical study, sperm were immobilized prior to injection by undergoing a rapid freeze-thaw procedure which did not include the use of cryoprotectants. Nine of the 20 injected oocytes demonstrated activation, and 6 of these oocytes demonstrated fertilization; however, cleavage was never assessed, as all oocytes were fixed 13 hr postinjection for electron microscopy evaluation.
Following this report, clinical studies were performed by Norfolk's laboratory (Veeck LL, Oehninger S, Acosta AA, Muasher S J, abstract) involving the transfer of ICSI-achieved embryos in wives of malefactor patients. All couples in that study either had failed fertilization previously or had an original sperm count <1 × 106/ml. Sperm here underwent the same rapid freeze-thaw procedure employed previously by Lanzendorf et al. (19) . This method of sperm preparation was used, as it was thought to make the sperm nucleus more easily accessible, as well as to facilitate immobilization. Thirty-two (26%) of the 122 oocytes injected fertilized; however, no pregnancies were established in the 16 patients who underwent transfer with these embryos, It was not until 1992 that the first report of human pregnancies achieved by the transfer of ICSI embryos was published (1). In that report, live immobilized sperm were used for injection. Most investigators have consequently attempted to inject "viable" sperm as assessed by either progressive motility or twitching movements. Immobilization is most commonly achieved by striking the midpiece or tail of the sperm with the injection pipette. The question has arisen as to the necessity of injecting only viable sperm; Could nonviable sperm also result in fertilization, cleavage, and eventual live births?
The birth of normal calves after the transfer of bovine embryos resulting from injection of nonviable sperm was reported in 1990 by Goto and co-workers (20) . Sperm in that study were immobilized and killed by twice freezing without addition of cryoprotectants. Viability staining was performed to confirm injection of nonviable sperm. In 1994, Hoshi et al. (21) reported the first human pregnancy and birth resulting from injection of "immobilized, killed sperm." Viability staining was, however, not performed following the freezing process, allowing for the possibility that the sperm used may have been immobilized but were not dead. These same investigators recently published another study in which they looked at the efficacy of various treatment modalities for oocyte activation when performing ICSI with both viable and nonviable sperm (14) . They concluded that, although nonviable sperm were capable of fertilizing an oocyte, they were perhaps incapable of activating the oocyte and, thus, required performance of positive activation measures (e.g., calcium ionophores or electroporation). Viability staining was again not performed.
In a study evaluating the relationship between sperm parameters and the result of ICSI, Nagy and coinvestigators (9) found that neither the type nor the severity of sperm impairment had an effect on fertilization, embryo cleavage, or pregnancies rates. However, the researchers did find that cases involving the injection of only nonmotile sperm resulted in very low rates of fertilization (10.9% in 12 clinical cases) and no pregnancies following five embryo transfers. They point out that in these 12 cases, the proportion of viable spermatozoa was about 10%, suggesting that 10% of the oocytes were probably injected with viable sperm. In the controlled study presented here, we have also found that nonmotile, nonviable human sperm are compromised in their ability to fertilize the injected oocyte, supporting previous clinical findings achieved with frozen-thawed sperm (19) and sperm obtained from individuals with no motile sperm (9) . Further investigations are required to determine if structural and/or functional differences exist between infertile individuals and the effect on fertilizing capacity following ICSI.
The present study was undertaken using immature, prophase I oocytes, a cohort that our program does not routinely utilize for insemination and embryo transfer. However, when patients do not have sufficient numbers of embryos for transfer, immature oocytes that have matured in vitro may be inseminated, although the pregnancy potential of these embryos has been low in our hands. Because they are typically not required for patient use, we felt it appropriate to use oocytes matured in vitro for research purposes with patients' consent. It should, therefore, be recognized that this study was performed with oocytes of a poorer quality and may have contributed to the findings reported here. However, the fertilization rate obtained with viable sperm in this study (62.2%; Table I ) is comparable to that obtained in. the clinical laboratory with oocytes both immature at aspiration (68.5%) and mature at aspiration (65.3%). In addition, the embryo cleavage rate following the injection of a viable sperm (91.3%; Table I ) is similar to that obtained with the clinical use of immature (94.4%) and mature (98.6%) oocytes. Therefore, we feel that the low rates of fertilization and embryo cleavage (16.2 and 33.3%, respectively; Table I ) seen following the injection of nonviable sperm is a true reflection of their potential.
In conclusion, we found that nonviable sperm (documented by viability staining), although capable of fertilizing the oocyte, failed to result consistently in normal cleavage. Only two embryos demonstrated cleavage; each divided once, with both exhibiting more than 50% fragmentation. It therefore seems unlikely that these embryos would have been capable of establishing a pregnancy had transfer been performed. Our data suggest that human sperm rendered nonviable by freeze-thawing may not be capable of resulting in normal embryos and therefore ICSI may not prove useful as a treatment modality in individuals with nonviable spermatozoa.
